Remove 2010 Remove Disease Remove Packaging
article thumbnail

DNA Analysis Finds New Target for Diabetes Drugs

NIH Director's Blog: Drug Development

But this approach doesn’t just provide predictions of risk; it may also provide a path to developing new ways of treating and preventing this serious, chronic disease that affects about 26 million Americans. Over time, this leads to heart disease, stroke, blindness, nerve damage, kidney damage, and amputations. J Clin Invest.

DNA 52
article thumbnail

Roche to launch SARS-CoV-2 Rapid Antigen Test in countries accepting CE mark, allowing fast triage decisions at point of care

The Pharma Data

We are working relentlessly to deliver solutions that help alleviate some of the healthcare burden with reliable SARS-CoV-2 testing solutions as we learn more about the disease and how it affects people around the world.”. SARS-CoV-2 Rapid Antigen Test package insert [2] European Centre for Disease Prevention and Control.

Virus 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Article EMA Thank You What will the orphan drug market exclusivity haircut mean for industry?

Agency IQ

Here, we’re starting some deeper analysis of aspects of the proposal package with a look at the impact of orphan drug provisions, seeing what impact the new provisions and the surrounding uncertainty might have on innovation. However, 95% of the over 6,000 recognized orphan diseases still have no treatment options. member states.

article thumbnail

Article EMA Thank You The devil is in the details: a deep dive into the state of Notified Body designations

Agency IQ

There are two codes that all 49 Notified Bodies received designation to – devices with a measuring function (MDS 1010) and devices that require packaging/labeling (MDT 2011). 23 MDS 1003 Devices manufactured utilising tissues or cells of animal origin, or their derivatives Section 5.3.2

article thumbnail

Analysis Life Sciences Thank You After 13-year review, FDA finalizes ‘clear, conspicuous and neutral’ drug advertising rule

Agency IQ

These standards were expected to be established within 30 months, or by March 27, 2010. And while it is mostly similar to what had been drafted in 2010, there are some notable changes. 1) When required. The rule comes into effect 180 days after it is made final by being published in the Federal Register.

FDA 40
article thumbnail

Discovering an Antimalarial Drug in Mao’s China

Codon

However, the blandly clinical package of artemisinin and artesunate tablets reveals little about how the key compound was first discovered. “Cumulatively the deadliest of the human infectious diseases,” malaria has been documented throughout recorded history. It was from these texts that artemisinin was rediscovered.

Drugs 140
article thumbnail

Codon Digest: Seeing Colors After Gene Therapy

Codon

CNGA3-achromatopsia is a hereditary disease that causes people to see in shades of gray. They’re talking about a patient who has a rare genetic disease. ” Gene-edited poplar tree stems appear red. The lighter stems are from wildtype poplar trees. From Sulis D.B. in Science. From McKyton et al. in Current Biology.